In breast cancer and various other malignancies, PTX and Dox have been reported to enhance the expression of major efflux transporters involved in drug resistance, including P-gp/MDR-1, MRP-1, and ABCG2/BCRP [24,25,26]. Here, ABCC1 is linked to breast carcinoma.